TrialJournal of neuro-oncology2018

JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.

Toshihiko Wakabayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.